Therapeutic Discovery Architects
Re-Designing Cancer Drug Discovery
Our Mission is to expedite development of more effective, personalised cancer treatments, through our unique combination of expertise, capability and access.
Purpose
Avatrial exists to save the lives of cancer patients by accelerating development of superior, personalised treatments for every patient.
Strategy
Our strategy is built around leveraging partnerships to ensure mutual, lasting benefit. We have created a unique end-to-end solution to expedite drug discovery.
Implementation
We can deliver faster and at a reduced cost because, at Avatrial, we not only have access to comprehensive ‘perfect’ data but also possess the right expertise, technology, infrastructure, and regulatory approvals.
Approach
Multi-Dimensional Data of Unprecedented Depth and Scale
We are generating complete low-noise datasets and training our machine learning (ML) algorithms on these. By incorporating state-of-the-art analytical tools and experimental models in-house, we can repeat, we can repeat the sample-data-hypothesis-validation cycle orders of magnitude faster and cheaper than previously possible.
Application
Our Value Proposition
Every year, 10 million patients die from cancer, and this number is expected to rise to over 15 million by 2040. Current treatments take 15-20 years to develop, with only a 1 in 5000 chance of approval. The success rate in clinical trials is below 15%. To save lives, we must radically re-architect the approach to drug discovery.
The development of effective cancer therapies, akin to other global challenges such as environmental issues, poverty, and conflict, is inherently complex and necessitates an Integrated Ecosystem approach. Addressing only one piece of such a complex puzzle in isolation will not lead to transformational change.
Avatrial’s strategy incorporates, in-house, all key steps necessary for cancer drug discovery: Access to donor samples, generation of unique and comprehensive datasets, AI/ML algorithms for data analysis, and state-of-the-art experimental models for validation of hits and hypotheses.
Avatrial’s Access, Capability and Expertise enables a unique end-to-end and integrated solution to cancer drug discovery that eliminates inefficiencies and vastly improves success
Our Partnerships with healthcare providers and healthy volunteers allow access to normal and diseased human tissue as meticulously curated ideal starting material linked with clinical data
Our Multi-omic Platform turns patient samples into comprehensive ‘perfect’ datasets with unprecedented depth, quality, speed and cost-effectiveness to enhance our understanding of health and disease
Our Data Platform uses Machine Learning algorithms trained on our ‘perfect’ low-noise healthy and disease datasets to discover new biomarkers and therapeutic targets
Our Experimental Platform incorporates a comprehensive array of state-of-the-art experimental methods for rapid and cost-effective hypothesis testing and validation of novel therapeutic targets
We are partnering with multiple healthcare organisations and technology providers and are looking to grow this partner network. If you are working in healthcare or technology and interested in partnering opportunities, please see our Partners page for more information or get in touch now.
Contact Us
[email protected]
Most emails are responded to within 48-72 hours.
Explore More
Find out more about what Avatrial has to offer